• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子(TNF)与 TNF 受体 1 和 2 相互作用的系统生物学模型。

A systems-biology model of the tumor necrosis factor (TNF) interactions with TNF receptor 1 and 2.

机构信息

Department of Bioinformatics, Biocenter, University of Würzburg, Würzburg 97074, Germany.

Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg 97080, Germany.

出版信息

Bioinformatics. 2021 May 5;37(5):669-676. doi: 10.1093/bioinformatics/btaa844.

DOI:10.1093/bioinformatics/btaa844
PMID:32991680
Abstract

MOTIVATION

Clustering enables TNF receptors to stimulate intracellular signaling. The differential soluble ligand-induced clustering behavior of TNF receptor 1 (TNFR1) and TNFR2 was modeled. A structured, rule-based model implemented ligand-independent pre-ligand binding assembly domain (PLAD)-mediated homotypic low affinity interactions of unliganded and liganded TNF receptors.

RESULTS

Soluble TNF initiates TNFR1 signaling but not TNFR2 signaling despite receptor binding unless it is secondarily oligomerized. We consider high affinity binding of TNF to signaling-incompetent pre-assembled dimeric TNFR1 and TNFR2 molecules and secondary clustering of liganded dimers to signaling competent ligand-receptor clusters. Published receptor numbers, affinities and measured different activities of clustered receptors validated model simulations for a large range of receptor and ligand concentrations. Different PLAD-PLAD affinities and different activities of receptor clusters explain the observed differences in the TNF receptor stimulating activities of soluble TNF.

AVAILABILITY AND IMPLEMENTATION

All scripts and data are in manuscript and supplement at Bioinformatics online.

SUPPLEMENTARY INFORMATION

Supplementary data are available at Bioinformatics online.

摘要

动机

聚类使 TNF 受体能够刺激细胞内信号转导。对 TNF 受体 1(TNFR1)和 TNFR2 的差异可溶性配体诱导的聚类行为进行了建模。一种基于结构的、基于规则的模型实现了无配体和配体 TNF 受体的配体非依赖性预配体结合组装域(PLAD)介导的同源低亲和力相互作用。

结果

尽管 TNF 受体结合,但可溶性 TNF 仅起始 TNFR1 信号转导而不起始 TNFR2 信号转导,除非其被次级寡聚化。我们考虑 TNF 与信号失活的预组装二聚体 TNFR1 和 TNFR2 分子的高亲和力结合,以及配体二聚体的次级聚集到信号有效配体-受体簇。已发表的受体数量、亲和力和测定的聚集受体的不同活性验证了模型模拟在很大的受体和配体浓度范围内的有效性。不同的 PLAD-PLAD 亲和力和受体簇的不同活性解释了可溶性 TNF 对 TNF 受体刺激活性的观察到的差异。

可用性和实现

所有脚本和数据都在 Bioinformatics 在线的手稿和补充材料中。

补充信息

补充数据可在 Bioinformatics 在线获得。

相似文献

1
A systems-biology model of the tumor necrosis factor (TNF) interactions with TNF receptor 1 and 2.肿瘤坏死因子(TNF)与 TNF 受体 1 和 2 相互作用的系统生物学模型。
Bioinformatics. 2021 May 5;37(5):669-676. doi: 10.1093/bioinformatics/btaa844.
2
Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2.单链 TNF 衍生物的受体结合位点单独发生突变,揭示了 TNFR1 和 TNFR2 配体-受体复合物形成的不同化学计量。
Cell Signal. 2010 Jul;22(7):1088-96. doi: 10.1016/j.cellsig.2010.02.011. Epub 2010 Mar 4.
3
Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies.缺乏颗粒蛋白前体与肿瘤坏死因子受体-1 和肿瘤坏死因子受体-2 直接相互作用的证据:来自细胞结合研究。
Front Immunol. 2018 Apr 23;9:793. doi: 10.3389/fimmu.2018.00793. eCollection 2018.
4
Mutations in the binding site of TNFR1 PLAD reduce homologous interactions but can enhance antagonism of wild-type TNFR1 activity.TNFR1PLAD 结合位点的突变减少了同源相互作用,但可以增强野生型 TNFR1 活性的拮抗作用。
Immunology. 2021 Nov;164(3):637-654. doi: 10.1111/imm.13400. Epub 2021 Aug 25.
5
Expression and purification of a natural N-terminal pre-ligand assembly domain of tumor necrosis factor receptor 1 (TNFR1 PLAD) and preliminary activity determination.肿瘤坏死因子受体 1(TNFR1 PLAD)天然 N 端前配体组装结构域的表达与纯化及初步活性测定。
Protein J. 2011 Apr;30(4):281-9. doi: 10.1007/s10930-011-9330-4.
6
Dual function of cysteine rich domain (CRD) 1 of TNF receptor type 1: conformational stabilization of CRD2 and control of receptor responsiveness.肿瘤坏死因子受体 1 富含半胱氨酸域(CRD)1 的双重功能:CRD2 的构象稳定和受体反应性的控制。
Cell Signal. 2010 Mar;22(3):404-14. doi: 10.1016/j.cellsig.2009.10.011.
7
Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors.通过靶向肿瘤坏死因子受体的配体前组装结构域改善炎性关节炎。
Nat Med. 2005 Oct;11(10):1066-72. doi: 10.1038/nm1304. Epub 2005 Sep 18.
8
Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.II型肿瘤坏死因子-α受体(TNFR2)激活c-Jun氨基末端激酶(JNK),但不激活丝裂原活化蛋白激酶(MAPK)或p38 MAPK信号通路。
Biochem J. 2001 Nov 1;359(Pt 3):525-35. doi: 10.1042/0264-6021:3590525.
9
Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.TNF-TNF 受体 2 信号在调节性 T 细胞中的作用及其治疗意义。
Front Immunol. 2018 Apr 19;9:784. doi: 10.3389/fimmu.2018.00784. eCollection 2018.
10
Quantitative single-molecule imaging of TNFR1 reveals zafirlukast as antagonist of TNFR1 clustering and TNFα-induced NF-ĸB signaling.定量单分子成像研究 TNFR1 揭示扎鲁司特是 TNFR1 聚集和 TNFα 诱导的 NF-κB 信号转导的拮抗剂。
J Leukoc Biol. 2021 Feb;109(2):363-371. doi: 10.1002/JLB.2AB0420-572RR. Epub 2020 May 13.

引用本文的文献

1
Tumor necrosis factor receptor 2 in allergen tolerance: a perspective view.变应原耐受中的肿瘤坏死因子受体2:前瞻性观点
Front Immunol. 2025 Jun 19;16:1613719. doi: 10.3389/fimmu.2025.1613719. eCollection 2025.
2
A New Histology-Based Prognostic Index for Acute Myeloid Leukemia: Preliminary Results for the "AML Urayasu Classification".一种基于组织学的急性髓系白血病新预后指数:“AML 浦安分类”的初步结果
J Clin Med. 2025 Mar 15;14(6):1989. doi: 10.3390/jcm14061989.
3
Emerging functions and therapeutic targets of IL-38 in central nervous system diseases.
白细胞介素-38在中枢神经系统疾病中的新功能及治疗靶点
CNS Neurosci Ther. 2024 Feb;30(2):e14550. doi: 10.1111/cns.14550.
4
Generic design principles for antibody-based tumour necrosis factor (TNF) receptor 2 (TNFR2) agonists with FcγR-independent agonism.基于抗体的肿瘤坏死因子 (TNF) 受体 2(TNFR2)激动剂的通用设计原则,具有 FcγR 非依赖性激动作用。
Theranostics. 2024 Jan 1;14(2):496-509. doi: 10.7150/thno.84404. eCollection 2024.
5
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond.肿瘤坏死因子(TNF)及其受体作为治疗风湿性疾病及其他疾病的靶点。
Nat Rev Rheumatol. 2023 Sep;19(9):576-591. doi: 10.1038/s41584-023-01002-7. Epub 2023 Aug 4.
6
How does the same ligand activate signaling of different receptors in TNFR superfamily: a computational study.相同配体如何激活肿瘤坏死因子受体超家族中不同受体的信号传导:一项计算研究
J Cell Commun Signal. 2023 Sep;17(3):657-671. doi: 10.1007/s12079-022-00701-2. Epub 2022 Sep 28.
7
Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy.肿瘤坏死因子受体2(TNFR2):癌症治疗中一个新兴的靶点。
Cancers (Basel). 2022 May 25;14(11):2603. doi: 10.3390/cancers14112603.
8
Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily.受体寡聚化及其与肿瘤坏死因子受体超家族受体信号传导的相关性。
Front Cell Dev Biol. 2021 Feb 11;8:615141. doi: 10.3389/fcell.2020.615141. eCollection 2020.